Kirschen Gregory W, Kim Ethan, Adsumelli Rishimani S N
From the Medical Scientist Training Program (MSTP), Stony Brook University School of Medicine, Stony Brook, New York.
Department of Anesthesia, Stony Brook University School of Medicine, Stony Brook, New York.
A A Pract. 2019 Feb 15;12(4):112-114. doi: 10.1213/XAA.0000000000000860.
Dexmedetomidine is an α2-adrenergic sedative-hypnotic medication used as an adjunct to general anesthesia. While experimental studies in animals have demonstrated a mild diuretic effect of dexmedetomidine, only recently have case reports described dexmedetomidine-induced diuresis in humans. Interestingly, the majority of such cases have involved patients undergoing spinal fusion surgery. Here, we report a case of a 30-year-old woman undergoing cervical spinal fusion surgery who experienced a massive diuresis starting 30 minutes after receiving dexmedetomidine intravenous infusion. We discuss the differential diagnosis and synthesize the current literature on this rare effect.
右美托咪定是一种α2肾上腺素能镇静催眠药物,用作全身麻醉的辅助药物。虽然动物实验研究已证明右美托咪定有轻度利尿作用,但直到最近才有病例报告描述了右美托咪定在人类中引起的利尿作用。有趣的是,大多数此类病例涉及接受脊柱融合手术的患者。在此,我们报告一例30岁接受颈椎融合手术的女性患者,在接受右美托咪定静脉输注30分钟后开始出现大量利尿。我们讨论了鉴别诊断并综合了关于这种罕见效应的当前文献。